- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Solid Malignancies in United Kingdom
Total 4340 results
-
BioMed Valley Discoveries, IncCompletedSolid Tumor MalignanciesUnited States
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingSolid Tumor | Hematologic Malignancy | Solid Tumor, Adult | Solid CarcinomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingSolid Tumor MalignanciesUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States, United Kingdom, Spain
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
Mayo ClinicRecruitingSolid Tumors | Hematologic MalignanciesUnited States
-
University of Wisconsin, MadisonPfizerCompletedSolid Malignancies | Metastatic Castrate-resistant Prostate CancerUnited States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
Human Genome Sciences Inc.TerminatedLymphoid MalignanciesUnited States, United Kingdom
-
Rhode Island HospitalUnknownSolid Tumors | Hematological MalignanciesUnited States
-
Roshni DasguptaRecruitingSolid Malignancies | Metastatic Disease | Primary TumorUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedCancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological MalignanciesUnited States
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.CompletedHematologic Malignancies | Malignant Solid TumorUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumor | Hematological MalignanciesUnited States
-
Calithera Biosciences, IncCompletedAdvanced Solid Tumor and Lymphoma MalignanciesUnited States, Spain, Italy, United Kingdom
-
Inova Health Care ServicesRecruitingSolid Tumor | Hematological MalignancyUnited States
-
Washington University School of MedicineAclaris Therapeutics, Inc.WithdrawnAdvanced Solid Tumor | Advanced Solid Tumor MalignanciesUnited States
-
National Cancer Institute (NCI)Enrolling by invitationSolid Tumors | Hematologic Malignancies | Pediatric CancersUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumors | Hematological MalignanciesUnited States
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Solid Tumors, Refractory/Relapsed Hematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterBTG International Inc.Terminated
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
Spectrum Pharmaceuticals, IncOnxeoCompletedSolid Tumor | Hematological MalignancyUnited States
-
Century Therapeutics, Inc.RecruitingHematological Malignancy | Solid Tumor MalignancyUnited States
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
BioInvent International ABMerck Sharp & Dohme LLCRecruitingAdvanced MalignanciesUnited Kingdom, Denmark, Hungary, Russian Federation
-
Dialectic Therapeutics, IncCompletedSolid Tumor | Hematologic MalignancyUnited States
-
Scripps Translational Science InstituteCompleted
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
City of Hope Medical CenterNational Institute on Aging (NIA)Active, not recruitingCancer | Solid Tumor | Hematologic MalignancyUnited States
-
PCI Biotech ASCompletedCutaneous or Sub-cutaneous MalignanciesUnited Kingdom
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
PfizerTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
Royal Marsden NHS Foundation TrustRecruitingSolid NeoplasmsUnited Kingdom
-
Genentech, Inc.CompletedSolid TumorUnited Kingdom
-
AstraZenecaCompleted
-
Dartmouth-Hitchcock Medical CenterRecruitingCancer | Hematologic Malignancy | Blood Cancer | Tumor, SolidUnited States
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more